Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess …

adjunctive treatment
seizure
antiepileptics
vagus nerve stimulation
brivaracetam
Ep0083 126
 (0.0 away) Contact site
  • 840 views
  • 19 Jun, 2021
  • +108 other locations
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +144 other locations
Study of Amivantamab a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non-Small Cell Lung Cancer

The purpose of study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of Amivantamab as a monotherapy and in combination with lazertinib, and to determine the recommended Phase 2 dose (RP2D) (monotherapy), recommended Phase 2 combination dose (RP2CD) (combination therapy), and to determine recommended Phase 2 Dose (RP2q3W) with …

growth factor
cancer chemotherapy
gefitinib
tyrosine
lung carcinoma
Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 24 May, 2021
  • +105 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
Kurume University Hospital
 (0.6 away) Contact site
  • 717 views
  • 19 Jun, 2021
  • +352 other locations
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or Crohn's disease (CD).

sigmoidoscopy or colonoscopy
ulcerative colitis
hematochezia
remission
ulceration
Hidaka Coloproctology Clinic
 (2.5 away) Contact site
  • 1349 views
  • 15 Jun, 2021
  • +824 other locations
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin FlexPro ) in Growth Hormone Treatment na ve Pre-pubertal Children With Growth Hormone Deficiency

This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of once-weekly NNC0195-0092 (somapacitan) treatment compared to daily growth hormone treatment (Norditropin FlexPro) in growth hormone treatment nave pre-pubertal children with growth hormone deficiency. The trial consists of a 26 week main trial period, …

Novo Nordisk Investigational Site
 (0.6 away) Contact site
  • 38 views
  • 09 May, 2021
  • +56 other locations
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.

fistulising crohn's disease
abdominal pain
ustekinumab
colitis
ileitis
Kurume University Hospital
 (0.6 away) Contact site
  • 792 views
  • 18 Jun, 2021
  • +796 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Kurume University Hospital /ID# 164427
 (0.6 away) Contact site
  • 604 views
  • 16 Jun, 2021
  • +772 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stemi
myocardial infarction
arterial disease
infarct
stroke
3920110 - Kurume University Hospital
 (0.6 away) Contact site
  • 1118 views
  • 18 Jun, 2021
  • +3422 other locations
An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

This study is an extension study for participants with primary immunodeficiency disorders who were previously treated with IGSC, 20% in the TAK-664-3001 study. They must have completed that study or be about to complete it before joining this study. Participants will continue treatment with IGCS, 20% in this study. The …

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +7 other locations